| carbamazepine / Generic mfg. |
NCT00236717: A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy |
|
|
| Completed | 3 | 865 | US | Topiramate; Carbamazepine; Valproate | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Epilepsy, Seizures | | 11/00 | | |
NCT00007670: Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. |
|
|
| Completed | 3 | 720 | US | Carbamazepine, Gabapentin, Lamotrigine | US Department of Veterans Affairs, Parke-Davis, Glaxo Wellcome | Seizures | | 03/03 | | |
NCT00150735: Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy |
|
|
| Completed | 3 | 580 | Europe, RoW | LEVETIRACETAM | UCB Pharma | Generalized Epilepsy | 07/05 | 07/05 | | |
NCT00150553: Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder |
|
|
| Completed | 3 | 102 | US | Extended-release carbamazepine | Validus Pharmaceuticals | Bipolar Disorder | | 10/05 | | |
NCT00150605: Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder |
|
|
| Completed | 3 | 50 | US | Extended-release carbamazepine | Validus Pharmaceuticals | Bipolar Disorder | | 10/05 | | |
NCT00150787: Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy. |
|
|
| Completed | 3 | 250 | Europe, RoW | LEVETIRACETAM | UCB Pharma | Epilepsy, Tonic-clonic | 11/05 | 11/05 | | |
NCT00175903 / 2004-001339-41: Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy |
|
|
| Completed | 3 | 1701 | Europe, RoW | Levetiracetam, Carbamazepine Controlled Release (CBZ-CR), Valproate Extended Release | UCB Pharma | Epilepsy | 10/07 | 10/07 | | |
NCT00266630: Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder |
|
|
| Completed | 3 | 139 | Japan | olanzapine, LY170053, Zyprexa, lithium, valproate, carbamazepine | Eli Lilly and Company | Manic or Mixed Episode Associated With Bipolar I Disorder | 05/09 | 05/09 | | |
NCT00477295 / 2006-000156-40: A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy |
|
|
| Completed | 3 | 583 | Europe, RoW | Zonisamide, Zonegran, Carbamazepine | Eisai Inc. | Epilepsy | 12/10 | 01/11 | | |
NCT00848549 / 2008-001159-23: Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures |
|
|
| Completed | 3 | 295 | Europe, RoW | Zonisamide, Zonegran, Carbamazepine | Eisai Inc. | Epilepsy | 06/11 | 11/11 | | |
| Terminated | 3 | 11 | Europe | Lacosamide, Vimpat, Levetiracetam, Keppra | UCB Pharma | Epilepsy, Partial | 03/13 | 03/13 | | |
SP0993, NCT01243177 / 2010-019765-28: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older |
|
|
| Completed | 3 | 888 | Europe, Canada, Japan, US, RoW | Lacosamide, Vimpat®, Carbamazepine-Controlled Release, Tegretol® Retard Tablets 200 mg | UCB BIOSCIENCES GmbH, Eden Sarl | Epilepsy, Monotherapy | 07/15 | 08/15 | | |
| Completed | 3 | 436 | RoW | Levetiracetam, Keppra, Carbamazepine, Tegretol | UCB Pharma SA | Epilepsy, Partial Seizures | 09/15 | 09/15 | | |
NCT01465997 / 2010-021238-74: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older |
|
|
| Completed | 3 | 551 | Canada, Japan, US, Europe, RoW | Lacosamide, VIMPAT film-coated tablets, Carbamazepine-Controlled Release (CBZ-CR), Tegretol® Retard Tablets 200 mg | UCB BIOSCIENCES GmbH, Eden Sarl | Epilepsy, Monotherapy | 01/17 | 01/17 | | |
